EGFR and lung adenocarcinoma: In one retrospective study of 410 patients with stage I lung adenocarcinoma, Isaka et al. showed that the EGFR exon 21 mutation was associated with low-grade adenocarcinoma with lepidic predominance, and that wild-type tumors were frequently high-grade tumors with vascular invasion [35].